Amdocs Limited Stock Fundamentals
| AOS Stock | EUR 81.24 1.00 1.22% |
Amdocs Limited fundamentals help investors to digest information that contributes to Amdocs' financial success or failures. It also enables traders to predict the movement of Amdocs Stock. The fundamental analysis module provides a way to measure Amdocs' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Amdocs stock.
Amdocs |
Amdocs Limited Company Current Valuation Analysis
Amdocs' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Amdocs Current Valuation | 10.29 B |
Most of Amdocs' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Amdocs Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Amdocs Limited has a Current Valuation of 10.29 B. This is 46.72% lower than that of the Technology sector and 90.79% lower than that of the Software - Infrastructure industry. The current valuation for all Germany stocks is 38.09% higher than that of the company.
Amdocs Limited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amdocs's current stock value. Our valuation model uses many indicators to compare Amdocs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amdocs competition to find correlations between indicators driving Amdocs's intrinsic value. More Info.Amdocs Limited is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers reporting about 0.43 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amdocs Limited is roughly 2.34 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Amdocs' earnings, one of the primary drivers of an investment's value.Amdocs Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Amdocs' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Amdocs could also be used in its relative valuation, which is a method of valuing Amdocs by comparing valuation metrics of similar companies.Amdocs is rated fifth in current valuation category among its peers.
Amdocs Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0652 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 10.29 B | |||
| Shares Outstanding | 120.59 M | |||
| Shares Owned By Insiders | 0.01 % | |||
| Shares Owned By Institutions | 98.75 % | |||
| Price To Earning | 22.06 X | |||
| Price To Book | 2.98 X | |||
| Price To Sales | 2.22 X | |||
| Revenue | 4.58 B | |||
| Gross Profit | 1.62 B | |||
| EBITDA | 899.33 M | |||
| Net Income | 549.5 M | |||
| Cash And Equivalents | 449.7 M | |||
| Cash Per Share | 3.28 X | |||
| Total Debt | 645.12 M | |||
| Debt To Equity | 3.30 % | |||
| Current Ratio | 1.35 X | |||
| Book Value Per Share | 29.42 X | |||
| Cash Flow From Operations | 756.72 M | |||
| Earnings Per Share | 4.18 X | |||
| Price To Earnings To Growth | 1.14 X | |||
| Target Price | 87.75 | |||
| Number Of Employees | 31 K | |||
| Beta | 0.66 | |||
| Market Capitalization | 10.24 B | |||
| Total Asset | 6.39 B | |||
| Z Score | 9.0 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.35 % | |||
| Net Asset | 6.39 B | |||
| Last Dividend Paid | 1.58 |
About Amdocs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Amdocs Limited's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Amdocs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Amdocs Limited based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company was founded in 1988 and is headquartered in Chesterfield, Missouri. AMDOCS LTD operates under Software - Infrastructure classification in Germany and is traded on Frankfurt Stock Exchange. It employs 25000 people.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Other Information on Investing in Amdocs Stock
Amdocs financial ratios help investors to determine whether Amdocs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Amdocs with respect to the benefits of owning Amdocs security.